Mary Ellen Reid, BSN, MSPH, PhD

Specialty: Prevention
Chief of Cancer Screening, Survivorship and Mentorship

 Request an Appointment
Locations

Roswell Park Main Campus
1-800-ROSWELL (1-800-767-9355)

Specializing In:

  • Preventative Care
  • Cancer Screening
  • Cancer Survivorship

Biography

I am the Chief of Cancer Screening, Survivorship and Mentorship at Roswell Park Comprehensive Cancer Center.  In my more than 20 years at Roswell Park, I am a Distinguished Professor of Oncology in the Department of Medicine and a key member of the Roswell Park scientific team that is collaborating with Cuban scientists on CIMAvax.  As Chief of Cancer Screening and Survivorship, I have worked to expand Roswell Park’s pioneering Lung Cancer Screening program and develop other cancer screening initiatives within the Institute and in the communities of Western New York, working closely with clinical departments and community providers, to increase the lung, colon and breast screening compliance. I have also established a comprehensive, multi-disciplinary survivorship clinical and outreach program.

Prior to joining Roswell Park, I received my PhD in Cancer Epidemiology at the University of Arizona in Tucson in 1996. I held the rank of Assistant Professor in the Division of Epidemiology and Biostatistics, at the College of Public Health and Co-Director of the NCI Cancer Prevention and Control Training Program. I have authored or co-authored more than 140 publications, five book chapters, and serves as a regular reviewer for several cancer, nutrition and epidemiology journals as well as a regular ad-hoc reviewer for several National Cancer Institute grant mechanisms.

Positions

Roswell Park Comprehensive Cancer Center

  • Professor of Oncology
  • Chief of Cancer Screening, Survivorship and Mentorship

State University of New York at Buffalo

  • Research Associate Professor
  • Department of Social and Preventative Medicine, School of Public Health

Background

Education and Training

  • PhD - Department of Epidemiology, School of Public Health, University of Arizona, Tucson, AZ
  • MSPH - Department of Epidemiology, Division of Public Health, University of Massachusetts, Amherst, MA
  • BSN - College of Nursing, Northeastern University, Boston, MA

Professional Memberships

  • 2010 - ACCP Lung Cancer Guidelines III, Lung Cancer Chemoprevention Chapter
  • 2010 - NCCN Lung Screening Consensus Committee Member
  • 2007 - International Association of the Study of Lung Cancer (IASLC), Member
  • 1998 - American Association for Cancer Research (AACR), Member

Research Overview

My research interests focus on the early detection and chemoprevention of lung and head and neck cancers, and the evaluation of genetic/epigenetic biomarkers of early lesions in high-risk populations.  

I oversee the High-Risk Lung Cancer Screening Program at Roswell Park, where high risk patients across the region are screened and recruited to studies using imaging and bronchoscopy, allowing for the collection of biospecimens for biomarker analyses. Currently, I am working on early phase clinical trials in the prevention of lung cancer and recurrence using CIMAvax, a vaccine developed in Cuba and Metformin.

Finally, based on the clinical programs in Screening and survivorship, I am an investigator on studies related to barriers to screening, methodology for implementing new community-based programs, and biomarkers and treatment strategies for long term symptom management among survivors.

Clinical Trials

Featured on CancerTalk

Publications

  Full Publications list on PubMed

Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR. (2002). Lung cancer incidence and selenium supplementation: an update of a clinical trial. CEBP, 11(11): 1285-1291. PMID: 12433704

Reid ME, Marshall JR, Roe D, Lebowitz M, Alberts DS, Battacharyya AK, Martinez ME. (2003). Smoking Exposure as a Risk Factor for Prevalent and Recurrent Colorectal Adenomas. CEBP, 12(10):1006-1011. PMID: 14578135

Evans R, Reid M, Segal B, Abrams SI, Lee K. (2018). Case Study in International Cooperation: Cuba’s Molecular Immunology Center and Roswell Park Cancer Institute. MEDICC Rev, 20(2):35-39. PMID: 29773775

Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, Perdomo C, Schaffer M, Liu G, Zhang S, Liu H, Vick J, Dhillon SS, Platero SJ, Dubinett SM, Stevenson C, Reid ME, Lenburg ME, Spira AE. (2019). Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions. Nat Commun, 10(1):1856. PMCID: PMC6478943

Flores T, Glaser KM, McDaniel D, Rokitka D, Amato KA, Reid ME**. (2019).  Building a comprehensive cancer survivorship program. Ecancermedicalscience, 13:992. PMCID: PMC6974369